{
	"info": {
		"_postman_id": "a79da9f3-0b52-4940-9178-0f0e6c696338",
		"name": "CatalogueUpdate",
		"schema": "https://schema.getpostman.com/json/collection/v2.1.0/collection.json",
		"_exporter_id": "30740337"
	},
	"item": [
		{
			"name": "https://author-p14102-e36686.adobeaemcloud.com/bin/catalogUpdatePathServlet.hp.json",
			"request": {
				"auth": {
					"type": "basic",
					"basic": [
						{
							"key": "password",
							"value": "bdb@123",
							"type": "string"
						},
						{
							"key": "username",
							"value": "bdproductdata",
							"type": "string"
						}
					]
				},
				"method": "POST",
				"header": [],
				"body": {
					"mode": "raw",
					"raw": "{\r\n  \"products\": [\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748684_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV563 Mouse Anti-Human CD62E 68-5H11\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 563 (BUV563) (355 nm/563 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 563, BUV 563, Brilliant UV 563, Brilliant UV563; CD62 antigen-like family member E; CD62E; E-selectin; ELAM; ELAM-1; ELAM1; endothelial adhesion molecule 1; Endothelial leukocyte adhesion molecule 1; ESEL; LECAM2; leukocyte endothelial cell adhesion molecule 2; Leukocyte-endothelial cell adhesion molecule 2; LYAM2; SELE; selectin E\",\r\n      \"pageDescription\": \"The 68-5H11 monoclonal antibody specifically binds to CD62E.\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"StandardSingleVial\",\r\n      \"labelDescription\": \"BUV563 Mouse Anti-Human CD62E\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The 68-5H11 monoclonal antibody specifically binds to CD62E. This adhesion molecule is a 97-115 kDa type I transmembrane glycoprotein that is encoded by the </span><span style=\\\"font-style:italic;font-family:Times,serif;font-size:9pt;\\\">SELE </span><span style=\\\"font-family:Times,serif;font-size:9pt;\\\">gene. CD62E is also known as E-selectin, Endothelial-leukocyte adhesion molecule-1 (ELAM-1), and Leukocyte endothelial cell adhesion molecule 2 (LECAM-2). CD62E is minimally expressed by unstimulated endothelium. Activated endothelial cells upregulate surface CD62E expression in response to various activators including inflammatory cytokines such as Interleukin-1 and Tumor Necrosis Factor. CD62E plays a role in leucocyte extravasation by promoting leucocyte rolling on activated endothelial cells during inflammation. CD62E may also play a role in the metastasis of certain tumor cells. The adhesion between endothelial CD62E molecules and a carbohydrate ligand on neutrophils is inhibited by the mAb 68-5H11.</span>  </p>\",\r\n      \"alternativeName\": \"SELE; E-selectin; Selectin E; ELAM; ELAM1; ESEL; LECAM2\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV563 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The antibody was conjugated to BD Horizon™ BUV563 which is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This dye is a tandem fluorochrome of BD Horizon BUV395 which has an Ex Max of 348 nm and an acceptor dye. The tandem has an Em Max at 563 nm. BD Horizon BUV563 can be excited by the 355 nm ultraviolet laser. On instruments with a 561 nm Yellow-Green laser, the recommended bandpass filter is 585/15 nm with a 535 nm long pass to minimize laser light leakage. When BD Horizon BUV563 is used with an instrument that does not have a 561 nm laser, a 560/40 nm filter with a 535 nm long pass may be more optimal. Due to the excitation and emission characteristics of the acceptor dye, there may be spillover into the PE and PE-CF594 detectors. However, the spillover can be corrected through compensation as with any other dye combination.</span>  </p>\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873088\",\r\n      \"specificity\": \"CD62E (E-Selectin)\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV563\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 563 (BUV563) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 350-nm and an acceptor dye with an emission maximum (Em Max) at 564-nm. BUV563, driven by BD innovation, is designed to be excited by the ultraviolet laser (355-nm) and detected using an optical filter centered near 560-nm (e.g., a 560/40 or a 585/15-nm bandpass filter). The acceptor dye can be excited by the Blue (488-nm) laser resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"564\",\r\n          \"excitationmax\": \"350\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"materialNumber\": \"748684\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP12367_748684\",\r\n          \"citationdata\": \"Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28934_748684\",\r\n          \"citationdata\": \"Goda K, Tanaka T, Takeuchi E, Miyasaka M. CD62E Workshop Panel report. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:416-418. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP12115_748684\",\r\n          \"citationdata\": \"Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 1989; 243(4895):1160-1165. (Biology).\",\r\n          \"pubMedId\": \"2466335\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP10710_748684\",\r\n          \"citationdata\": \"Phillips ML, Nudelman E, Gaeta FC, et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science. 1990; 250(4984):1130-1132. (Biology).\",\r\n          \"pubMedId\": \"1701274\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28935_748684\",\r\n          \"citationdata\": \"Vermont-Desroches C, Roy C, Marchand D, Wijdenes J. CD62E Workshop: The Workshop \\\"CD62E,\\\" CD62L,\\\" \\\"CD102\\\" and \\\"CD106\\\" monoclonal antibodies: Analysis of the monoclonal antibody specificity, epitope mapping, and biological activity. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:418-419. \",\r\n          \"pubMedId\": \"\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"dyeName\": \"BUV563\",\r\n          \"tdsCloneName\": \"68-5H11\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"68-5H11\",\r\n          \"workshopNumber\": \"VI A090\",\r\n          \"immunogen\": \"\",\r\n          \"tdsCloneName\": \"68-5H11\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"612920\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748719_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV737 Mouse Anti-Human CD45 HI30\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 737 (BUV737) (355 nm/737 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 737, BUV 737, Brilliant UV 737, Brilliant UV737; LCA; LY5; B220; CD45; L-CA; T200; CD45R; GP180; IMD105; receptor-type tyrosine-protein phosphatase C;CD45 antigen; T200 glycoprotein; T200 leukocyte common antigen; protein tyrosine phosphatase, receptor type, c polypeptide; protein tyrosine phosphatase receptor type C\",\r\n      \"pageDescription\": \"The HI30 monoclonal antibody specifically binds to the 180, 190, 205, 220 kDa protein isoforms of CD45.\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"SingleVial2022\",\r\n      \"labelDescription\": \"BUV737 Mouse Anti-Human CD45\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The HI30 monoclonal antibody specifically binds to the 180, 190, 205, 220 kDa protein isoforms of CD45. CD45 is encoded by the </span><span style=\\\"font-style:italic;font-family:Times,serif;font-size:9pt;\\\">PTPRC (</span><span style=\\\"font-family:Times,serif;font-size:9pt;\\\">Protein tyrosine phosphatase receptor type C) gene. CD45, also known as the leukocyte common antigen (LCA), is a member of the protein tyrosine phosphatase (PTP) family. It is present on all human leukocytes including lymphocytes, monocytes, granulocytes, eosinophils, and thymocytes. CD45 is absent from circulating erythrocytes, platelets, or mature erythroid cells of bone marrow and non-hemopoietic tissues.</span>  </p>\",\r\n      \"alternativeName\": \"PTPRC; LCA; L-CA; Leukocyte Common Antigen; T200; GP180; LY5\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li><li>BD Horizon Brilliant Ultraviolet 737 is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,227,187; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV737 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873123\",\r\n      \"specificity\": \"CD45\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV737\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 737 (BUV737) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 350-nm and an acceptor dye with an emission maximum (Em Max) at 735-nm. BUV737, driven by BD innovation, is designed to be excited by the ultraviolet laser (355-nm) and detected using an optical filter centered near 740-nm (e.g., 740/35 bandpass filter). The acceptor dye can be excited by the Red (628–640nm) laser resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"735\",\r\n          \"excitationmax\": \"350\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"materialNumber\": \"748719\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP25442_748719\",\r\n          \"citationdata\": \"Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol. 2003; 21:107-137. (Biology).\",\r\n          \"pubMedId\": \"12414720\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP7469_748719\",\r\n          \"citationdata\": \"Knapp W. W. Knapp .. et al., ed. Leucocyte typing IV : white cell differentiation antigens. Oxford  New York: Oxford University Press; 1989:1-1182. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP25441_748719\",\r\n          \"citationdata\": \"Loken MR, Brosnan JM, Bach BA, Ault KA. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry. 1990; 11(4):453-459. (Methodology).\",\r\n          \"pubMedId\": \"1693112\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28200_748719\",\r\n          \"citationdata\": \"Zola H. Leukocyte and stromal cell molecules : the CD markers. Hoboken, N.J.: Wiley-Liss; 2007. \",\r\n          \"pubMedId\": \"\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"dyeName\": \"BUV737\",\r\n          \"tdsCloneName\": \"HI30\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"HI30\",\r\n          \"workshopNumber\": \"IV N816\",\r\n          \"immunogen\": \"Human Peripheral Blood Leucocytes \",\r\n          \"tdsCloneName\": \"HI30\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"612758\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748718_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV563 Mouse Anti-Human CD92 VIM15\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 563 (BUV563) (355 nm/563 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 563, BUV 563, Brilliant UV 563, Brilliant UV563; SLC44A1; Choline transporter-like protein 1; CHTL1; CTL1; RP11-287A8.1; p70\",\r\n      \"pageDescription\": \"The VIM15 monoclonal antibody specifically binds to CD92 which is also known as Solute carrier family 44 member 1 (SLC44A1), or Choline transporter-like protein 1 (CHTL1).\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"SingleVial2022\",\r\n      \"labelDescription\": \"BUV563 Mouse Anti-Human CD92\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The VIM15 monoclonal antibody specifically binds to CD92 which is also known as Solute carrier family 44 member 1 (SLC44A1), or Choline transporter-like protein 1 (CHTL1). CD92 is a multipass membrane glycoprotein that belongs to the choline transporter-like family. It contains a tyrosine-based inhibitory motif (ITIM) in its cytoplasmic C-terminus. CD92 appears to be involved in choline transport for cell membrane phospholipid synthesis and in regulatory cell-signaling pathways. CD92 is strongly expressed by monocytes and at lower levels by granulocytes and some dendritic cells. It is generally expressed at low levels by B cells, endothelial cells, epithelial cells, and subsets of T cells, or NK cells. The VIM15 antibody has been shown to augment lipopolysaccharide-induced IL-10 production by monocyte-derived dendritic cells (Mo-DC). When cultured with ionomycin or calcium ionophore, maturing Mo-DC showed downregulation of CD92 expression.</span>  </p>\",\r\n      \"alternativeName\": \"SLC44A1; Choline transporter-like protein 1; CHTL1; CTL1; RP11-287A8.1; p70\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV563 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873122\",\r\n      \"specificity\": \"CD92\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV563\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 563 (BUV563) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 350-nm and an acceptor dye with an emission maximum (Em Max) at 564-nm. BUV563, driven by BD innovation, is designed to be excited by the ultraviolet laser (355-nm) and detected using an optical filter centered near 560-nm (e.g., a 560/40 or a 585/15-nm bandpass filter). The acceptor dye can be excited by the Blue (488-nm) laser resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"564\",\r\n          \"excitationmax\": \"350\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"materialNumber\": \"748718\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP29682_748718\",\r\n          \"citationdata\": \"Wille S, Szekeres A, Majdic O, et al. Characterization of CDw92 as a member of the choline transporter-like protein family regulated specifically on dendritic cells. J Immunol. 2001; 167(10):5795-5804. (Immunogen).\",\r\n          \"pubMedId\": \"11698453\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP29683_748718\",\r\n          \"citationdata\": \"Pickl WF, Majdic O, Kohl P, et al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol. 1996; 157(9):3850-3859. (Clone-specific).\",\r\n          \"pubMedId\": \"8892615\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28408_748718\",\r\n          \"citationdata\": \"Zola H, Swart B, Banham A, et al. CD molecules 2006--human cell differentiation molecules.. J Immunol Methods. 2007; 319(1-2):1-5. (Clone-specific).\",\r\n          \"pubMedId\": \"17174972\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP29689_748718\",\r\n          \"citationdata\": \"Majdic O, Mai I, Pickl WF, Stockinger H, Knapp W. CDw92 (group 9) cluster workshop report. In: Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995:984-985. \",\r\n          \"pubMedId\": \"\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"dyeName\": \"BUV563\",\r\n          \"tdsCloneName\": \"VIM15\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"VIM15\",\r\n          \"workshopNumber\": \"V M15; HCDM 2006\",\r\n          \"immunogen\": \"Human Myeloid Cell Line MV4-11 \",\r\n          \"tdsCloneName\": \"VIM15\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"612920\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748682_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV805 Mouse Anti-Human CD62E 68-5H11\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 805 (BUV805) (355 nm/805 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 805, BUV 805, Brilliant UV 805, Brilliant UV805; CD62 antigen-like family member E; CD62E; E-selectin; ELAM; ELAM-1; ELAM1; endothelial adhesion molecule 1; Endothelial leukocyte adhesion molecule 1; ESEL; LECAM2; leukocyte endothelial cell adhesion molecule 2; Leukocyte-endothelial cell adhesion molecule 2; LYAM2; SELE; selectin E\",\r\n      \"pageDescription\": \"The 68-5H11 monoclonal antibody specifically binds to CD62E.\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"StandardSingleVial\",\r\n      \"labelDescription\": \"BUV805 Mouse Anti-Human CD62E\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The 68-5H11 monoclonal antibody specifically binds to CD62E. This adhesion molecule is a 97-115 kDa type I transmembrane glycoprotein that is encoded by the </span><span style=\\\"font-style:italic;font-family:Times,serif;font-size:9pt;\\\">SELE </span><span style=\\\"font-family:Times,serif;font-size:9pt;\\\">gene. CD62E is also known as E-selectin, Endothelial-leukocyte adhesion molecule-1 (ELAM-1), and Leukocyte endothelial cell adhesion molecule 2 (LECAM-2). CD62E is minimally expressed by unstimulated endothelium. Activated endothelial cells upregulate surface CD62E expression in response to various activators including inflammatory cytokines such as Interleukin-1 and Tumor Necrosis Factor. CD62E plays a role in leucocyte extravasation by promoting leucocyte rolling on activated endothelial cells during inflammation. CD62E may also play a role in the metastasis of certain tumor cells. The adhesion between endothelial CD62E molecules and a carbohydrate ligand on neutrophils is inhibited by the mAb 68-5H11.</span>  </p>\",\r\n      \"alternativeName\": \"SELE; E-selectin; Selectin E; ELAM; ELAM1; ESEL; LECAM2\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li><li>BD Horizon Brilliant Ultraviolet 805 is covered by one or more of the following US patents: 8,110,673, 8,158,444; 8,227,187; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV805 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The antibody was conjugated to BD Horizon™ BUV805 which is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This dye is a tandem fluorochrome of BD Horizon BUV395 with an Ex Max of 348 nm and an acceptor dye with an Em Max at 805 nm. BD Horizon Brilliant BUV805 can be excited by the ultraviolet laser (355 nm) and detected with a 820/60 filter and a 770LP.</span>  </p>\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873086\",\r\n      \"specificity\": \"CD62E (E-Selectin)\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV805\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 805 (BUV805) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 351-nm and an acceptor dye with an emission maximum (Em Max) at 803-nm. BUV805, driven by BD innovation, is designed to be excited by the ultraviolet laser (355 nm) and detected using an optical filter centered near 805-nm (e.g., a 820/60 or a 780/60 bandpass filter).  Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"803\",\r\n          \"excitationmax\": \"351\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"materialNumber\": \"748682\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP12367_748682\",\r\n          \"citationdata\": \"Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28934_748682\",\r\n          \"citationdata\": \"Goda K, Tanaka T, Takeuchi E, Miyasaka M. CD62E Workshop Panel report. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:416-418. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP12115_748682\",\r\n          \"citationdata\": \"Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 1989; 243(4895):1160-1165. (Biology).\",\r\n          \"pubMedId\": \"2466335\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP10710_748682\",\r\n          \"citationdata\": \"Phillips ML, Nudelman E, Gaeta FC, et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science. 1990; 250(4984):1130-1132. (Biology).\",\r\n          \"pubMedId\": \"1701274\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28935_748682\",\r\n          \"citationdata\": \"Vermont-Desroches C, Roy C, Marchand D, Wijdenes J. CD62E Workshop: The Workshop \\\"CD62E,\\\" CD62L,\\\" \\\"CD102\\\" and \\\"CD106\\\" monoclonal antibodies: Analysis of the monoclonal antibody specificity, epitope mapping, and biological activity. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:418-419. \",\r\n          \"pubMedId\": \"\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"dyeName\": \"BUV805\",\r\n          \"tdsCloneName\": \"68-5H11\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"68-5H11\",\r\n          \"workshopNumber\": \"VI A090\",\r\n          \"immunogen\": \"\",\r\n          \"tdsCloneName\": \"68-5H11\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"612897\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748716_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV805 Mouse Anti-Human CD92 VIM15\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 805 (BUV805) (355 nm/805 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 805, BUV 805, Brilliant UV 805, Brilliant UV805; SLC44A1; Choline transporter-like protein 1; CHTL1; CTL1; RP11-287A8.1; p70\",\r\n      \"pageDescription\": \"The VIM15 monoclonal antibody specifically binds to CD92 which is also known as Solute carrier family 44 member 1 (SLC44A1), or Choline transporter-like protein 1 (CHTL1).\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"SingleVial2022\",\r\n      \"labelDescription\": \"BUV805 Mouse Anti-Human CD92\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The VIM15 monoclonal antibody specifically binds to CD92 which is also known as Solute carrier family 44 member 1 (SLC44A1), or Choline transporter-like protein 1 (CHTL1). CD92 is a multipass membrane glycoprotein that belongs to the choline transporter-like family. It contains a tyrosine-based inhibitory motif (ITIM) in its cytoplasmic C-terminus. CD92 appears to be involved in choline transport for cell membrane phospholipid synthesis and in regulatory cell-signaling pathways. CD92 is strongly expressed by monocytes and at lower levels by granulocytes and some dendritic cells. It is generally expressed at low levels by B cells, endothelial cells, epithelial cells, and subsets of T cells, or NK cells. The VIM15 antibody has been shown to augment lipopolysaccharide-induced IL-10 production by monocyte-derived dendritic cells (Mo-DC). When cultured with ionomycin or calcium ionophore, maturing Mo-DC showed downregulation of CD92 expression.</span>  </p>\",\r\n      \"alternativeName\": \"SLC44A1; Choline transporter-like protein 1; CHTL1; CTL1; RP11-287A8.1; p70\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li><li>BD Horizon Brilliant Ultraviolet 805 is covered by one or more of the following US patents: 8,110,673, 8,158,444; 8,227,187; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV805 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873120\",\r\n      \"specificity\": \"CD92\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV805\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 805 (BUV805) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 351-nm and an acceptor dye with an emission maximum (Em Max) at 803-nm. BUV805, driven by BD innovation, is designed to be excited by the ultraviolet laser (355 nm) and detected using an optical filter centered near 805-nm (e.g., a 820/60 or a 780/60 bandpass filter).  Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"803\",\r\n          \"excitationmax\": \"351\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"materialNumber\": \"748716\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP29682_748716\",\r\n          \"citationdata\": \"Wille S, Szekeres A, Majdic O, et al. Characterization of CDw92 as a member of the choline transporter-like protein family regulated specifically on dendritic cells. J Immunol. 2001; 167(10):5795-5804. (Immunogen).\",\r\n          \"pubMedId\": \"11698453\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP29683_748716\",\r\n          \"citationdata\": \"Pickl WF, Majdic O, Kohl P, et al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol. 1996; 157(9):3850-3859. (Clone-specific).\",\r\n          \"pubMedId\": \"8892615\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28408_748716\",\r\n          \"citationdata\": \"Zola H, Swart B, Banham A, et al. CD molecules 2006--human cell differentiation molecules.. J Immunol Methods. 2007; 319(1-2):1-5. (Clone-specific).\",\r\n          \"pubMedId\": \"17174972\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP29689_748716\",\r\n          \"citationdata\": \"Majdic O, Mai I, Pickl WF, Stockinger H, Knapp W. CDw92 (group 9) cluster workshop report. In: Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995:984-985. \",\r\n          \"pubMedId\": \"\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"dyeName\": \"BUV805\",\r\n          \"tdsCloneName\": \"VIM15\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"VIM15\",\r\n          \"workshopNumber\": \"V M15; HCDM 2006\",\r\n          \"immunogen\": \"Human Myeloid Cell Line MV4-11 \",\r\n          \"tdsCloneName\": \"VIM15\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"612897\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748685_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV805 Mouse Anti-Human P-glycoprotein (CD243) 15D3\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 805 (BUV805) (355 nm/805 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 805, BUV 805, Brilliant UV 805, Brilliant UV805; CLCS; MDR1; P-GP; PGY1; ABC20; CD243; GP170; p-170; ATP-dependent translocase ABCB1;ATP-binding cassette, sub-family B (MDR/TAP), member 1; P-glycoprotein 1; colchicin sensitivity; doxorubicin resistance; multidrug resistance protein 1; phospholipid transporter ABCB1; ATP binding cassette subfamily B member 1\",\r\n      \"pageDescription\": \"The 15D3 monoclonal antibody specifically recognizes P-glycoprotein which is also known as CD243, ATP-binding cassette subfamily B member 1 (ABCB1) or Multidrug resistance protein 1 (MDR1).\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"StandardSingleVial\",\r\n      \"labelDescription\": \"BUV805 Mouse Anti-Human P-glycoprotein (CD243)\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The 15D3 monoclonal antibody specifically recognizes P-glycoprotein which is also known as CD243, ATP-binding cassette subfamily B member 1 (ABCB1) or Multidrug resistance protein 1 (MDR1). P-glycoprotein is a ~170 kDa transmembrane glycoprotein  protein that spans the membrane 12 times. P-glycoprotein acts as an ATP-dependent efflux pump for a large variety of drugs. It may be expressed at high levels by multidrug resistant (MDR) tumor cells. This efflux activity may lead to cellular resistance to the drugs used in chemotherapy. P-glycoprotein is present in many normal cell types including endothelial, epithelial, or secretory cells, and might protect them from naturally occurring xenobiotics.</span>  </p>\",\r\n      \"alternativeName\": \"ABCB1; ABC20; CLCS; GP170; MDR1; P-GP; PGY1; pgp 170\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li><li>BD Horizon Brilliant Ultraviolet 805 is covered by one or more of the following US patents: 8,110,673, 8,158,444; 8,227,187; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV805 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The antibody was conjugated to BD Horizon™ BUV805 which is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This dye is a tandem fluorochrome of BD Horizon BUV395 with an Ex Max of 348 nm and an acceptor dye with an Em Max at 805 nm. BD Horizon Brilliant BUV805 can be excited by the ultraviolet laser (355 nm) and detected with a 820/60 filter and a 770LP.</span>  </p>\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873089\",\r\n      \"specificity\": \"P-glycoprotein (MDR1)\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV805\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 805 (BUV805) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 351-nm and an acceptor dye with an emission maximum (Em Max) at 803-nm. BUV805, driven by BD innovation, is designed to be excited by the ultraviolet laser (355 nm) and detected using an optical filter centered near 805-nm (e.g., a 820/60 or a 780/60 bandpass filter).  Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"803\",\r\n          \"excitationmax\": \"351\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"materialNumber\": \"748685\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP15595_748685\",\r\n          \"citationdata\": \"Shi T, Wrin J, Reeder J, Liu D, Ring DB. High-affinity monoclonal antibodies against P-glycoprotein. Clin Immunol Immunopathol. 1995; 76(1):44-51. (Immunogen).\",\r\n          \"pubMedId\": \"7541735\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31047_748685\",\r\n          \"citationdata\": \"List AF. Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia.. Leukemia. 1996; 10(6):937-42. (Biology).\",\r\n          \"pubMedId\": \"8667648\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31048_748685\",\r\n          \"citationdata\": \"Filipits M, Suchomel RW, Dekan G, et al. MRP and MDR1 gene expression in primary breast carcinomas.. Clin Cancer Res. 1996; 2(7):1231-7. (Biology).\",\r\n          \"pubMedId\": \"9816292\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31049_748685\",\r\n          \"citationdata\": \"Beck WT, Grogan TM, Willman CL, et al. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.. Cancer Res. 1996; 56(13):3010-20. (Biology).\",\r\n          \"pubMedId\": \"8674056\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31053_748685\",\r\n          \"citationdata\": \"Klimecki WT, Futscher BW, Grogan TM, Dalton WS. P-glycoprotein expression and function in circulating blood cells from normal volunteers.. Blood. 1994; 83(9):2451-8. (Biology).\",\r\n          \"pubMedId\": \"7513198\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31050_748685\",\r\n          \"citationdata\": \"Chan HS, Haddad G, Zheng L, Bradley G, Dalton WS, Ling V. Sensitive immunofluorescence detection of the expression of P-glycoprotein in malignant cells.. Cytometry. 1997; 29(1):65-75. (Biology).\",\r\n          \"pubMedId\": \"9298813\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31051_748685\",\r\n          \"citationdata\": \"Drach D, Zhao S, Drach J, et al. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.. Blood. 1992; 80(11):2729-34. (Biology).\",\r\n          \"pubMedId\": \"1360266\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31052_748685\",\r\n          \"citationdata\": \"Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.. Blood. 1992; 80(11):2735-9. (Biology).\",\r\n          \"pubMedId\": \"1360267\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31054_748685\",\r\n          \"citationdata\": \"Dalton WS, Durie BG, Alberts DS, Gerlach JH, Cress AE. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein.. Cancer Res. 1986; 46(10):5125-30. (Biology).\",\r\n          \"pubMedId\": \"2875788\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"dyeName\": \"BUV805\",\r\n          \"tdsCloneName\": \"15D3\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"BALB/c\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"15D3\",\r\n          \"workshopNumber\": \"\",\r\n          \"immunogen\": \"MDR1-transfected BATV.2 cells \",\r\n          \"tdsCloneName\": \"15D3\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"612897\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748717_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV737 Mouse Anti-Human CD92 VIM15\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 737 (BUV737) (355 nm/737 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 737, BUV 737, Brilliant UV 737, Brilliant UV737; SLC44A1; Choline transporter-like protein 1; CHTL1; CTL1; RP11-287A8.1; p70\",\r\n      \"pageDescription\": \"The VIM15 monoclonal antibody specifically binds to CD92 which is also known as Solute carrier family 44 member 1 (SLC44A1), or Choline transporter-like protein 1 (CHTL1).\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"SingleVial2022\",\r\n      \"labelDescription\": \"BUV737 Mouse Anti-Human CD92\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The VIM15 monoclonal antibody specifically binds to CD92 which is also known as Solute carrier family 44 member 1 (SLC44A1), or Choline transporter-like protein 1 (CHTL1). CD92 is a multipass membrane glycoprotein that belongs to the choline transporter-like family. It contains a tyrosine-based inhibitory motif (ITIM) in its cytoplasmic C-terminus. CD92 appears to be involved in choline transport for cell membrane phospholipid synthesis and in regulatory cell-signaling pathways. CD92 is strongly expressed by monocytes and at lower levels by granulocytes and some dendritic cells. It is generally expressed at low levels by B cells, endothelial cells, epithelial cells, and subsets of T cells, or NK cells. The VIM15 antibody has been shown to augment lipopolysaccharide-induced IL-10 production by monocyte-derived dendritic cells (Mo-DC). When cultured with ionomycin or calcium ionophore, maturing Mo-DC showed downregulation of CD92 expression.</span>  </p>\",\r\n      \"alternativeName\": \"SLC44A1; Choline transporter-like protein 1; CHTL1; CTL1; RP11-287A8.1; p70\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li><li>BD Horizon Brilliant Ultraviolet 737 is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,227,187; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV737 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873121\",\r\n      \"specificity\": \"CD92\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV737\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 737 (BUV737) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 350-nm and an acceptor dye with an emission maximum (Em Max) at 735-nm. BUV737, driven by BD innovation, is designed to be excited by the ultraviolet laser (355-nm) and detected using an optical filter centered near 740-nm (e.g., 740/35 bandpass filter). The acceptor dye can be excited by the Red (628–640nm) laser resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"735\",\r\n          \"excitationmax\": \"350\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"materialNumber\": \"748717\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP29682_748717\",\r\n          \"citationdata\": \"Wille S, Szekeres A, Majdic O, et al. Characterization of CDw92 as a member of the choline transporter-like protein family regulated specifically on dendritic cells. J Immunol. 2001; 167(10):5795-5804. (Immunogen).\",\r\n          \"pubMedId\": \"11698453\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP29683_748717\",\r\n          \"citationdata\": \"Pickl WF, Majdic O, Kohl P, et al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol. 1996; 157(9):3850-3859. (Clone-specific).\",\r\n          \"pubMedId\": \"8892615\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28408_748717\",\r\n          \"citationdata\": \"Zola H, Swart B, Banham A, et al. CD molecules 2006--human cell differentiation molecules.. J Immunol Methods. 2007; 319(1-2):1-5. (Clone-specific).\",\r\n          \"pubMedId\": \"17174972\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP29689_748717\",\r\n          \"citationdata\": \"Majdic O, Mai I, Pickl WF, Stockinger H, Knapp W. CDw92 (group 9) cluster workshop report. In: Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995:984-985. \",\r\n          \"pubMedId\": \"\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"dyeName\": \"BUV737\",\r\n          \"tdsCloneName\": \"VIM15\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"VIM15\",\r\n          \"workshopNumber\": \"V M15; HCDM 2006\",\r\n          \"immunogen\": \"Human Myeloid Cell Line MV4-11 \",\r\n          \"tdsCloneName\": \"VIM15\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"612758\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748683_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV737 Mouse Anti-Human CD62E 68-5H11\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 737 (BUV737) (355 nm/737 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 737, BUV 737, Brilliant UV 737, Brilliant UV737; CD62 antigen-like family member E; CD62E; E-selectin; ELAM; ELAM-1; ELAM1; endothelial adhesion molecule 1; Endothelial leukocyte adhesion molecule 1; ESEL; LECAM2; leukocyte endothelial cell adhesion molecule 2; Leukocyte-endothelial cell adhesion molecule 2; LYAM2; SELE; selectin E\",\r\n      \"pageDescription\": \"The 68-5H11 monoclonal antibody specifically binds to CD62E.\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"StandardSingleVial\",\r\n      \"labelDescription\": \"BUV737 Mouse Anti-Human CD62E\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The 68-5H11 monoclonal antibody specifically binds to CD62E. This adhesion molecule is a 97-115 kDa type I transmembrane glycoprotein that is encoded by the </span><span style=\\\"font-style:italic;font-family:Times,serif;font-size:9pt;\\\">SELE </span><span style=\\\"font-family:Times,serif;font-size:9pt;\\\">gene. CD62E is also known as E-selectin, Endothelial-leukocyte adhesion molecule-1 (ELAM-1), and Leukocyte endothelial cell adhesion molecule 2 (LECAM-2). CD62E is minimally expressed by unstimulated endothelium. Activated endothelial cells upregulate surface CD62E expression in response to various activators including inflammatory cytokines such as Interleukin-1 and Tumor Necrosis Factor. CD62E plays a role in leucocyte extravasation by promoting leucocyte rolling on activated endothelial cells during inflammation. CD62E may also play a role in the metastasis of certain tumor cells. The adhesion between endothelial CD62E molecules and a carbohydrate ligand on neutrophils is inhibited by the mAb 68-5H11.</span>  </p>\",\r\n      \"alternativeName\": \"SELE; E-selectin; Selectin E; ELAM; ELAM1; ESEL; LECAM2\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li><li>BD Horizon Brilliant Ultraviolet 737 is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,227,187; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV737 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The antibody was conjugated to BD Horizon™ BUV737 which is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This dye is a tandem fluorochrome of BD Horizon BUV395 with an Ex Max of 348-nm and an acceptor dye with an Em Max at 737-nm. BD Horizon Brilliant BUV737 can be excited by the ultraviolet laser (355 nm) and detected with a 740/35 filter.  Due to the excitation of the acceptor dye by other laser lines, there may be significant spillover into channels detecting Alexa Fluor® 700-like dyes (eg, 712/20-nm filter). </span>  </p>  <p></p>  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">Due to spectral differences between labeled cells and beads, using BD™ CompBeads can result in incorrect spillover values when used with BD Horizon BUV737 reagents. Therefore, the use of BD CompBeads or BD CompBeads Plus to determine spillover values for these reagents is not recommended. Different BUV737 reagents (eg, CD4 vs. CD45) can have slightly different fluorescence spillover therefore, it may also be necessary to use clone specific compensation controls when using these reagents.</span>  </p>\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873087\",\r\n      \"specificity\": \"CD62E (E-Selectin)\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV737\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 737 (BUV737) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 350-nm and an acceptor dye with an emission maximum (Em Max) at 735-nm. BUV737, driven by BD innovation, is designed to be excited by the ultraviolet laser (355-nm) and detected using an optical filter centered near 740-nm (e.g., 740/35 bandpass filter). The acceptor dye can be excited by the Red (628–640nm) laser resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"735\",\r\n          \"excitationmax\": \"350\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"materialNumber\": \"748683\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP12367_748683\",\r\n          \"citationdata\": \"Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28934_748683\",\r\n          \"citationdata\": \"Goda K, Tanaka T, Takeuchi E, Miyasaka M. CD62E Workshop Panel report. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:416-418. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28935_748683\",\r\n          \"citationdata\": \"Vermont-Desroches C, Roy C, Marchand D, Wijdenes J. CD62E Workshop: The Workshop \\\"CD62E,\\\" CD62L,\\\" \\\"CD102\\\" and \\\"CD106\\\" monoclonal antibodies: Analysis of the monoclonal antibody specificity, epitope mapping, and biological activity. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:418-419. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP10710_748683\",\r\n          \"citationdata\": \"Phillips ML, Nudelman E, Gaeta FC, et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science. 1990; 250(4984):1130-1132. (Biology).\",\r\n          \"pubMedId\": \"1701274\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP12115_748683\",\r\n          \"citationdata\": \"Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 1989; 243(4895):1160-1165. (Biology).\",\r\n          \"pubMedId\": \"2466335\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"dyeName\": \"BUV737\",\r\n          \"tdsCloneName\": \"68-5H11\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"68-5H11\",\r\n          \"workshopNumber\": \"VI A090\",\r\n          \"immunogen\": \"\",\r\n          \"tdsCloneName\": \"68-5H11\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"612758\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    }\r\n  ]\r\n}"
				},
				"url": {
					"raw": "https://author-p14102-e36686.adobeaemcloud.com/bin/catalogUpdatePathServlet.hp.json",
					"protocol": "https",
					"host": [
						"author-p14102-e36686",
						"adobeaemcloud",
						"com"
					],
					"path": [
						"bin",
						"catalogUpdatePathServlet.hp.json"
					]
				}
			},
			"response": []
		},
		{
			"name": "local",
			"request": {
				"auth": {
					"type": "basic",
					"basic": [
						{
							"key": "password",
							"value": "admin",
							"type": "string"
						},
						{
							"key": "username",
							"value": "admin",
							"type": "string"
						}
					]
				},
				"method": "POST",
				"header": [],
				"body": {
					"mode": "raw",
					"raw": "{\r\n  \"products\": [\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748684_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV563 Mouse Anti-Human CD62E 68-5H11\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 563 (BUV563) (355 nm/563 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 563, BUV 563, Brilliant UV 563, Brilliant UV563; CD62 antigen-like family member E; CD62E; E-selectin; ELAM; ELAM-1; ELAM1; endothelial adhesion molecule 1; Endothelial leukocyte adhesion molecule 1; ESEL; LECAM2; leukocyte endothelial cell adhesion molecule 2; Leukocyte-endothelial cell adhesion molecule 2; LYAM2; SELE; selectin E\",\r\n      \"pageDescription\": \"The 68-5H11 monoclonal antibody specifically binds to CD62E.\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"StandardSingleVial\",\r\n      \"labelDescription\": \"BUV563 Mouse Anti-Human CD62E\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The 68-5H11 monoclonal antibody specifically binds to CD62E. This adhesion molecule is a 97-115 kDa type I transmembrane glycoprotein that is encoded by the </span><span style=\\\"font-style:italic;font-family:Times,serif;font-size:9pt;\\\">SELE </span><span style=\\\"font-family:Times,serif;font-size:9pt;\\\">gene. CD62E is also known as E-selectin, Endothelial-leukocyte adhesion molecule-1 (ELAM-1), and Leukocyte endothelial cell adhesion molecule 2 (LECAM-2). CD62E is minimally expressed by unstimulated endothelium. Activated endothelial cells upregulate surface CD62E expression in response to various activators including inflammatory cytokines such as Interleukin-1 and Tumor Necrosis Factor. CD62E plays a role in leucocyte extravasation by promoting leucocyte rolling on activated endothelial cells during inflammation. CD62E may also play a role in the metastasis of certain tumor cells. The adhesion between endothelial CD62E molecules and a carbohydrate ligand on neutrophils is inhibited by the mAb 68-5H11.</span>  </p>\",\r\n      \"alternativeName\": \"SELE; E-selectin; Selectin E; ELAM; ELAM1; ESEL; LECAM2\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV563 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The antibody was conjugated to BD Horizon™ BUV563 which is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This dye is a tandem fluorochrome of BD Horizon BUV395 which has an Ex Max of 348 nm and an acceptor dye. The tandem has an Em Max at 563 nm. BD Horizon BUV563 can be excited by the 355 nm ultraviolet laser. On instruments with a 561 nm Yellow-Green laser, the recommended bandpass filter is 585/15 nm with a 535 nm long pass to minimize laser light leakage. When BD Horizon BUV563 is used with an instrument that does not have a 561 nm laser, a 560/40 nm filter with a 535 nm long pass may be more optimal. Due to the excitation and emission characteristics of the acceptor dye, there may be spillover into the PE and PE-CF594 detectors. However, the spillover can be corrected through compensation as with any other dye combination.</span>  </p>\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873088\",\r\n      \"specificity\": \"CD62E (E-Selectin)\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV563\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 563 (BUV563) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 350-nm and an acceptor dye with an emission maximum (Em Max) at 564-nm. BUV563, driven by BD innovation, is designed to be excited by the ultraviolet laser (355-nm) and detected using an optical filter centered near 560-nm (e.g., a 560/40 or a 585/15-nm bandpass filter). The acceptor dye can be excited by the Blue (488-nm) laser resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"564\",\r\n          \"excitationmax\": \"350\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"materialNumber\": \"748684\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP12367_748684\",\r\n          \"citationdata\": \"Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28934_748684\",\r\n          \"citationdata\": \"Goda K, Tanaka T, Takeuchi E, Miyasaka M. CD62E Workshop Panel report. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:416-418. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP12115_748684\",\r\n          \"citationdata\": \"Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 1989; 243(4895):1160-1165. (Biology).\",\r\n          \"pubMedId\": \"2466335\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP10710_748684\",\r\n          \"citationdata\": \"Phillips ML, Nudelman E, Gaeta FC, et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science. 1990; 250(4984):1130-1132. (Biology).\",\r\n          \"pubMedId\": \"1701274\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28935_748684\",\r\n          \"citationdata\": \"Vermont-Desroches C, Roy C, Marchand D, Wijdenes J. CD62E Workshop: The Workshop \\\"CD62E,\\\" CD62L,\\\" \\\"CD102\\\" and \\\"CD106\\\" monoclonal antibodies: Analysis of the monoclonal antibody specificity, epitope mapping, and biological activity. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:418-419. \",\r\n          \"pubMedId\": \"\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"dyeName\": \"BUV563\",\r\n          \"tdsCloneName\": \"68-5H11\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"68-5H11\",\r\n          \"workshopNumber\": \"VI A090\",\r\n          \"immunogen\": \"\",\r\n          \"tdsCloneName\": \"68-5H11\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748684_base\",\r\n          \"companionMaterialNumber\": \"612920\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748719_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV737 Mouse Anti-Human CD45 HI30\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 737 (BUV737) (355 nm/737 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 737, BUV 737, Brilliant UV 737, Brilliant UV737; LCA; LY5; B220; CD45; L-CA; T200; CD45R; GP180; IMD105; receptor-type tyrosine-protein phosphatase C;CD45 antigen; T200 glycoprotein; T200 leukocyte common antigen; protein tyrosine phosphatase, receptor type, c polypeptide; protein tyrosine phosphatase receptor type C\",\r\n      \"pageDescription\": \"The HI30 monoclonal antibody specifically binds to the 180, 190, 205, 220 kDa protein isoforms of CD45.\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"SingleVial2022\",\r\n      \"labelDescription\": \"BUV737 Mouse Anti-Human CD45\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The HI30 monoclonal antibody specifically binds to the 180, 190, 205, 220 kDa protein isoforms of CD45. CD45 is encoded by the </span><span style=\\\"font-style:italic;font-family:Times,serif;font-size:9pt;\\\">PTPRC (</span><span style=\\\"font-family:Times,serif;font-size:9pt;\\\">Protein tyrosine phosphatase receptor type C) gene. CD45, also known as the leukocyte common antigen (LCA), is a member of the protein tyrosine phosphatase (PTP) family. It is present on all human leukocytes including lymphocytes, monocytes, granulocytes, eosinophils, and thymocytes. CD45 is absent from circulating erythrocytes, platelets, or mature erythroid cells of bone marrow and non-hemopoietic tissues.</span>  </p>\",\r\n      \"alternativeName\": \"PTPRC; LCA; L-CA; Leukocyte Common Antigen; T200; GP180; LY5\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li><li>BD Horizon Brilliant Ultraviolet 737 is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,227,187; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV737 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873123\",\r\n      \"specificity\": \"CD45\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV737\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 737 (BUV737) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 350-nm and an acceptor dye with an emission maximum (Em Max) at 735-nm. BUV737, driven by BD innovation, is designed to be excited by the ultraviolet laser (355-nm) and detected using an optical filter centered near 740-nm (e.g., 740/35 bandpass filter). The acceptor dye can be excited by the Red (628–640nm) laser resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"735\",\r\n          \"excitationmax\": \"350\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"materialNumber\": \"748719\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP25442_748719\",\r\n          \"citationdata\": \"Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol. 2003; 21:107-137. (Biology).\",\r\n          \"pubMedId\": \"12414720\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP7469_748719\",\r\n          \"citationdata\": \"Knapp W. W. Knapp .. et al., ed. Leucocyte typing IV : white cell differentiation antigens. Oxford  New York: Oxford University Press; 1989:1-1182. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP25441_748719\",\r\n          \"citationdata\": \"Loken MR, Brosnan JM, Bach BA, Ault KA. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry. 1990; 11(4):453-459. (Methodology).\",\r\n          \"pubMedId\": \"1693112\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28200_748719\",\r\n          \"citationdata\": \"Zola H. Leukocyte and stromal cell molecules : the CD markers. Hoboken, N.J.: Wiley-Liss; 2007. \",\r\n          \"pubMedId\": \"\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"dyeName\": \"BUV737\",\r\n          \"tdsCloneName\": \"HI30\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"HI30\",\r\n          \"workshopNumber\": \"IV N816\",\r\n          \"immunogen\": \"Human Peripheral Blood Leucocytes \",\r\n          \"tdsCloneName\": \"HI30\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748719_base\",\r\n          \"companionMaterialNumber\": \"612758\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748718_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV563 Mouse Anti-Human CD92 VIM15\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 563 (BUV563) (355 nm/563 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 563, BUV 563, Brilliant UV 563, Brilliant UV563; SLC44A1; Choline transporter-like protein 1; CHTL1; CTL1; RP11-287A8.1; p70\",\r\n      \"pageDescription\": \"The VIM15 monoclonal antibody specifically binds to CD92 which is also known as Solute carrier family 44 member 1 (SLC44A1), or Choline transporter-like protein 1 (CHTL1).\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"SingleVial2022\",\r\n      \"labelDescription\": \"BUV563 Mouse Anti-Human CD92\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The VIM15 monoclonal antibody specifically binds to CD92 which is also known as Solute carrier family 44 member 1 (SLC44A1), or Choline transporter-like protein 1 (CHTL1). CD92 is a multipass membrane glycoprotein that belongs to the choline transporter-like family. It contains a tyrosine-based inhibitory motif (ITIM) in its cytoplasmic C-terminus. CD92 appears to be involved in choline transport for cell membrane phospholipid synthesis and in regulatory cell-signaling pathways. CD92 is strongly expressed by monocytes and at lower levels by granulocytes and some dendritic cells. It is generally expressed at low levels by B cells, endothelial cells, epithelial cells, and subsets of T cells, or NK cells. The VIM15 antibody has been shown to augment lipopolysaccharide-induced IL-10 production by monocyte-derived dendritic cells (Mo-DC). When cultured with ionomycin or calcium ionophore, maturing Mo-DC showed downregulation of CD92 expression.</span>  </p>\",\r\n      \"alternativeName\": \"SLC44A1; Choline transporter-like protein 1; CHTL1; CTL1; RP11-287A8.1; p70\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV563 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873122\",\r\n      \"specificity\": \"CD92\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV563\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 563 (BUV563) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 350-nm and an acceptor dye with an emission maximum (Em Max) at 564-nm. BUV563, driven by BD innovation, is designed to be excited by the ultraviolet laser (355-nm) and detected using an optical filter centered near 560-nm (e.g., a 560/40 or a 585/15-nm bandpass filter). The acceptor dye can be excited by the Blue (488-nm) laser resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"564\",\r\n          \"excitationmax\": \"350\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"materialNumber\": \"748718\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP29682_748718\",\r\n          \"citationdata\": \"Wille S, Szekeres A, Majdic O, et al. Characterization of CDw92 as a member of the choline transporter-like protein family regulated specifically on dendritic cells. J Immunol. 2001; 167(10):5795-5804. (Immunogen).\",\r\n          \"pubMedId\": \"11698453\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP29683_748718\",\r\n          \"citationdata\": \"Pickl WF, Majdic O, Kohl P, et al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol. 1996; 157(9):3850-3859. (Clone-specific).\",\r\n          \"pubMedId\": \"8892615\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28408_748718\",\r\n          \"citationdata\": \"Zola H, Swart B, Banham A, et al. CD molecules 2006--human cell differentiation molecules.. J Immunol Methods. 2007; 319(1-2):1-5. (Clone-specific).\",\r\n          \"pubMedId\": \"17174972\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP29689_748718\",\r\n          \"citationdata\": \"Majdic O, Mai I, Pickl WF, Stockinger H, Knapp W. CDw92 (group 9) cluster workshop report. In: Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995:984-985. \",\r\n          \"pubMedId\": \"\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"dyeName\": \"BUV563\",\r\n          \"tdsCloneName\": \"VIM15\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"VIM15\",\r\n          \"workshopNumber\": \"V M15; HCDM 2006\",\r\n          \"immunogen\": \"Human Myeloid Cell Line MV4-11 \",\r\n          \"tdsCloneName\": \"VIM15\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748718_base\",\r\n          \"companionMaterialNumber\": \"612920\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748682_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV805 Mouse Anti-Human CD62E 68-5H11\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 805 (BUV805) (355 nm/805 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 805, BUV 805, Brilliant UV 805, Brilliant UV805; CD62 antigen-like family member E; CD62E; E-selectin; ELAM; ELAM-1; ELAM1; endothelial adhesion molecule 1; Endothelial leukocyte adhesion molecule 1; ESEL; LECAM2; leukocyte endothelial cell adhesion molecule 2; Leukocyte-endothelial cell adhesion molecule 2; LYAM2; SELE; selectin E\",\r\n      \"pageDescription\": \"The 68-5H11 monoclonal antibody specifically binds to CD62E.\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"StandardSingleVial\",\r\n      \"labelDescription\": \"BUV805 Mouse Anti-Human CD62E\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The 68-5H11 monoclonal antibody specifically binds to CD62E. This adhesion molecule is a 97-115 kDa type I transmembrane glycoprotein that is encoded by the </span><span style=\\\"font-style:italic;font-family:Times,serif;font-size:9pt;\\\">SELE </span><span style=\\\"font-family:Times,serif;font-size:9pt;\\\">gene. CD62E is also known as E-selectin, Endothelial-leukocyte adhesion molecule-1 (ELAM-1), and Leukocyte endothelial cell adhesion molecule 2 (LECAM-2). CD62E is minimally expressed by unstimulated endothelium. Activated endothelial cells upregulate surface CD62E expression in response to various activators including inflammatory cytokines such as Interleukin-1 and Tumor Necrosis Factor. CD62E plays a role in leucocyte extravasation by promoting leucocyte rolling on activated endothelial cells during inflammation. CD62E may also play a role in the metastasis of certain tumor cells. The adhesion between endothelial CD62E molecules and a carbohydrate ligand on neutrophils is inhibited by the mAb 68-5H11.</span>  </p>\",\r\n      \"alternativeName\": \"SELE; E-selectin; Selectin E; ELAM; ELAM1; ESEL; LECAM2\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li><li>BD Horizon Brilliant Ultraviolet 805 is covered by one or more of the following US patents: 8,110,673, 8,158,444; 8,227,187; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV805 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The antibody was conjugated to BD Horizon™ BUV805 which is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This dye is a tandem fluorochrome of BD Horizon BUV395 with an Ex Max of 348 nm and an acceptor dye with an Em Max at 805 nm. BD Horizon Brilliant BUV805 can be excited by the ultraviolet laser (355 nm) and detected with a 820/60 filter and a 770LP.</span>  </p>\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873086\",\r\n      \"specificity\": \"CD62E (E-Selectin)\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV805\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 805 (BUV805) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 351-nm and an acceptor dye with an emission maximum (Em Max) at 803-nm. BUV805, driven by BD innovation, is designed to be excited by the ultraviolet laser (355 nm) and detected using an optical filter centered near 805-nm (e.g., a 820/60 or a 780/60 bandpass filter).  Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"803\",\r\n          \"excitationmax\": \"351\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"materialNumber\": \"748682\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP12367_748682\",\r\n          \"citationdata\": \"Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28934_748682\",\r\n          \"citationdata\": \"Goda K, Tanaka T, Takeuchi E, Miyasaka M. CD62E Workshop Panel report. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:416-418. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP12115_748682\",\r\n          \"citationdata\": \"Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 1989; 243(4895):1160-1165. (Biology).\",\r\n          \"pubMedId\": \"2466335\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP10710_748682\",\r\n          \"citationdata\": \"Phillips ML, Nudelman E, Gaeta FC, et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science. 1990; 250(4984):1130-1132. (Biology).\",\r\n          \"pubMedId\": \"1701274\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28935_748682\",\r\n          \"citationdata\": \"Vermont-Desroches C, Roy C, Marchand D, Wijdenes J. CD62E Workshop: The Workshop \\\"CD62E,\\\" CD62L,\\\" \\\"CD102\\\" and \\\"CD106\\\" monoclonal antibodies: Analysis of the monoclonal antibody specificity, epitope mapping, and biological activity. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:418-419. \",\r\n          \"pubMedId\": \"\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"dyeName\": \"BUV805\",\r\n          \"tdsCloneName\": \"68-5H11\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"68-5H11\",\r\n          \"workshopNumber\": \"VI A090\",\r\n          \"immunogen\": \"\",\r\n          \"tdsCloneName\": \"68-5H11\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748682_base\",\r\n          \"companionMaterialNumber\": \"612897\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748716_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV805 Mouse Anti-Human CD92 VIM15\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 805 (BUV805) (355 nm/805 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 805, BUV 805, Brilliant UV 805, Brilliant UV805; SLC44A1; Choline transporter-like protein 1; CHTL1; CTL1; RP11-287A8.1; p70\",\r\n      \"pageDescription\": \"The VIM15 monoclonal antibody specifically binds to CD92 which is also known as Solute carrier family 44 member 1 (SLC44A1), or Choline transporter-like protein 1 (CHTL1).\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"SingleVial2022\",\r\n      \"labelDescription\": \"BUV805 Mouse Anti-Human CD92\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The VIM15 monoclonal antibody specifically binds to CD92 which is also known as Solute carrier family 44 member 1 (SLC44A1), or Choline transporter-like protein 1 (CHTL1). CD92 is a multipass membrane glycoprotein that belongs to the choline transporter-like family. It contains a tyrosine-based inhibitory motif (ITIM) in its cytoplasmic C-terminus. CD92 appears to be involved in choline transport for cell membrane phospholipid synthesis and in regulatory cell-signaling pathways. CD92 is strongly expressed by monocytes and at lower levels by granulocytes and some dendritic cells. It is generally expressed at low levels by B cells, endothelial cells, epithelial cells, and subsets of T cells, or NK cells. The VIM15 antibody has been shown to augment lipopolysaccharide-induced IL-10 production by monocyte-derived dendritic cells (Mo-DC). When cultured with ionomycin or calcium ionophore, maturing Mo-DC showed downregulation of CD92 expression.</span>  </p>\",\r\n      \"alternativeName\": \"SLC44A1; Choline transporter-like protein 1; CHTL1; CTL1; RP11-287A8.1; p70\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li><li>BD Horizon Brilliant Ultraviolet 805 is covered by one or more of the following US patents: 8,110,673, 8,158,444; 8,227,187; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV805 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873120\",\r\n      \"specificity\": \"CD92\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV805\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 805 (BUV805) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 351-nm and an acceptor dye with an emission maximum (Em Max) at 803-nm. BUV805, driven by BD innovation, is designed to be excited by the ultraviolet laser (355 nm) and detected using an optical filter centered near 805-nm (e.g., a 820/60 or a 780/60 bandpass filter).  Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"803\",\r\n          \"excitationmax\": \"351\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"materialNumber\": \"748716\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP29682_748716\",\r\n          \"citationdata\": \"Wille S, Szekeres A, Majdic O, et al. Characterization of CDw92 as a member of the choline transporter-like protein family regulated specifically on dendritic cells. J Immunol. 2001; 167(10):5795-5804. (Immunogen).\",\r\n          \"pubMedId\": \"11698453\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP29683_748716\",\r\n          \"citationdata\": \"Pickl WF, Majdic O, Kohl P, et al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol. 1996; 157(9):3850-3859. (Clone-specific).\",\r\n          \"pubMedId\": \"8892615\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28408_748716\",\r\n          \"citationdata\": \"Zola H, Swart B, Banham A, et al. CD molecules 2006--human cell differentiation molecules.. J Immunol Methods. 2007; 319(1-2):1-5. (Clone-specific).\",\r\n          \"pubMedId\": \"17174972\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP29689_748716\",\r\n          \"citationdata\": \"Majdic O, Mai I, Pickl WF, Stockinger H, Knapp W. CDw92 (group 9) cluster workshop report. In: Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995:984-985. \",\r\n          \"pubMedId\": \"\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"dyeName\": \"BUV805\",\r\n          \"tdsCloneName\": \"VIM15\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"VIM15\",\r\n          \"workshopNumber\": \"V M15; HCDM 2006\",\r\n          \"immunogen\": \"Human Myeloid Cell Line MV4-11 \",\r\n          \"tdsCloneName\": \"VIM15\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748716_base\",\r\n          \"companionMaterialNumber\": \"612897\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748685_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV805 Mouse Anti-Human P-glycoprotein (CD243) 15D3\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 805 (BUV805) (355 nm/805 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 805, BUV 805, Brilliant UV 805, Brilliant UV805; CLCS; MDR1; P-GP; PGY1; ABC20; CD243; GP170; p-170; ATP-dependent translocase ABCB1;ATP-binding cassette, sub-family B (MDR/TAP), member 1; P-glycoprotein 1; colchicin sensitivity; doxorubicin resistance; multidrug resistance protein 1; phospholipid transporter ABCB1; ATP binding cassette subfamily B member 1\",\r\n      \"pageDescription\": \"The 15D3 monoclonal antibody specifically recognizes P-glycoprotein which is also known as CD243, ATP-binding cassette subfamily B member 1 (ABCB1) or Multidrug resistance protein 1 (MDR1).\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"StandardSingleVial\",\r\n      \"labelDescription\": \"BUV805 Mouse Anti-Human P-glycoprotein (CD243)\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The 15D3 monoclonal antibody specifically recognizes P-glycoprotein which is also known as CD243, ATP-binding cassette subfamily B member 1 (ABCB1) or Multidrug resistance protein 1 (MDR1). P-glycoprotein is a ~170 kDa transmembrane glycoprotein  protein that spans the membrane 12 times. P-glycoprotein acts as an ATP-dependent efflux pump for a large variety of drugs. It may be expressed at high levels by multidrug resistant (MDR) tumor cells. This efflux activity may lead to cellular resistance to the drugs used in chemotherapy. P-glycoprotein is present in many normal cell types including endothelial, epithelial, or secretory cells, and might protect them from naturally occurring xenobiotics.</span>  </p>\",\r\n      \"alternativeName\": \"ABCB1; ABC20; CLCS; GP170; MDR1; P-GP; PGY1; pgp 170\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li><li>BD Horizon Brilliant Ultraviolet 805 is covered by one or more of the following US patents: 8,110,673, 8,158,444; 8,227,187; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV805 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The antibody was conjugated to BD Horizon™ BUV805 which is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This dye is a tandem fluorochrome of BD Horizon BUV395 with an Ex Max of 348 nm and an acceptor dye with an Em Max at 805 nm. BD Horizon Brilliant BUV805 can be excited by the ultraviolet laser (355 nm) and detected with a 820/60 filter and a 770LP.</span>  </p>\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873089\",\r\n      \"specificity\": \"P-glycoprotein (MDR1)\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV805\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 805 (BUV805) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 351-nm and an acceptor dye with an emission maximum (Em Max) at 803-nm. BUV805, driven by BD innovation, is designed to be excited by the ultraviolet laser (355 nm) and detected using an optical filter centered near 805-nm (e.g., a 820/60 or a 780/60 bandpass filter).  Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"803\",\r\n          \"excitationmax\": \"351\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"materialNumber\": \"748685\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP15595_748685\",\r\n          \"citationdata\": \"Shi T, Wrin J, Reeder J, Liu D, Ring DB. High-affinity monoclonal antibodies against P-glycoprotein. Clin Immunol Immunopathol. 1995; 76(1):44-51. (Immunogen).\",\r\n          \"pubMedId\": \"7541735\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31047_748685\",\r\n          \"citationdata\": \"List AF. Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia.. Leukemia. 1996; 10(6):937-42. (Biology).\",\r\n          \"pubMedId\": \"8667648\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31048_748685\",\r\n          \"citationdata\": \"Filipits M, Suchomel RW, Dekan G, et al. MRP and MDR1 gene expression in primary breast carcinomas.. Clin Cancer Res. 1996; 2(7):1231-7. (Biology).\",\r\n          \"pubMedId\": \"9816292\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31049_748685\",\r\n          \"citationdata\": \"Beck WT, Grogan TM, Willman CL, et al. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.. Cancer Res. 1996; 56(13):3010-20. (Biology).\",\r\n          \"pubMedId\": \"8674056\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31053_748685\",\r\n          \"citationdata\": \"Klimecki WT, Futscher BW, Grogan TM, Dalton WS. P-glycoprotein expression and function in circulating blood cells from normal volunteers.. Blood. 1994; 83(9):2451-8. (Biology).\",\r\n          \"pubMedId\": \"7513198\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31050_748685\",\r\n          \"citationdata\": \"Chan HS, Haddad G, Zheng L, Bradley G, Dalton WS, Ling V. Sensitive immunofluorescence detection of the expression of P-glycoprotein in malignant cells.. Cytometry. 1997; 29(1):65-75. (Biology).\",\r\n          \"pubMedId\": \"9298813\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31051_748685\",\r\n          \"citationdata\": \"Drach D, Zhao S, Drach J, et al. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.. Blood. 1992; 80(11):2729-34. (Biology).\",\r\n          \"pubMedId\": \"1360266\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31052_748685\",\r\n          \"citationdata\": \"Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.. Blood. 1992; 80(11):2735-9. (Biology).\",\r\n          \"pubMedId\": \"1360267\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP31054_748685\",\r\n          \"citationdata\": \"Dalton WS, Durie BG, Alberts DS, Gerlach JH, Cress AE. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein.. Cancer Res. 1986; 46(10):5125-30. (Biology).\",\r\n          \"pubMedId\": \"2875788\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"dyeName\": \"BUV805\",\r\n          \"tdsCloneName\": \"15D3\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"BALB/c\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"15D3\",\r\n          \"workshopNumber\": \"\",\r\n          \"immunogen\": \"MDR1-transfected BATV.2 cells \",\r\n          \"tdsCloneName\": \"15D3\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748685_base\",\r\n          \"companionMaterialNumber\": \"612897\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748717_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV737 Mouse Anti-Human CD92 VIM15\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 737 (BUV737) (355 nm/737 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 737, BUV 737, Brilliant UV 737, Brilliant UV737; SLC44A1; Choline transporter-like protein 1; CHTL1; CTL1; RP11-287A8.1; p70\",\r\n      \"pageDescription\": \"The VIM15 monoclonal antibody specifically binds to CD92 which is also known as Solute carrier family 44 member 1 (SLC44A1), or Choline transporter-like protein 1 (CHTL1).\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"SingleVial2022\",\r\n      \"labelDescription\": \"BUV737 Mouse Anti-Human CD92\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The VIM15 monoclonal antibody specifically binds to CD92 which is also known as Solute carrier family 44 member 1 (SLC44A1), or Choline transporter-like protein 1 (CHTL1). CD92 is a multipass membrane glycoprotein that belongs to the choline transporter-like family. It contains a tyrosine-based inhibitory motif (ITIM) in its cytoplasmic C-terminus. CD92 appears to be involved in choline transport for cell membrane phospholipid synthesis and in regulatory cell-signaling pathways. CD92 is strongly expressed by monocytes and at lower levels by granulocytes and some dendritic cells. It is generally expressed at low levels by B cells, endothelial cells, epithelial cells, and subsets of T cells, or NK cells. The VIM15 antibody has been shown to augment lipopolysaccharide-induced IL-10 production by monocyte-derived dendritic cells (Mo-DC). When cultured with ionomycin or calcium ionophore, maturing Mo-DC showed downregulation of CD92 expression.</span>  </p>\",\r\n      \"alternativeName\": \"SLC44A1; Choline transporter-like protein 1; CHTL1; CTL1; RP11-287A8.1; p70\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li><li>BD Horizon Brilliant Ultraviolet 737 is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,227,187; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV737 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873121\",\r\n      \"specificity\": \"CD92\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV737\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 737 (BUV737) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 350-nm and an acceptor dye with an emission maximum (Em Max) at 735-nm. BUV737, driven by BD innovation, is designed to be excited by the ultraviolet laser (355-nm) and detected using an optical filter centered near 740-nm (e.g., 740/35 bandpass filter). The acceptor dye can be excited by the Red (628–640nm) laser resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"735\",\r\n          \"excitationmax\": \"350\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"materialNumber\": \"748717\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP29682_748717\",\r\n          \"citationdata\": \"Wille S, Szekeres A, Majdic O, et al. Characterization of CDw92 as a member of the choline transporter-like protein family regulated specifically on dendritic cells. J Immunol. 2001; 167(10):5795-5804. (Immunogen).\",\r\n          \"pubMedId\": \"11698453\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP29683_748717\",\r\n          \"citationdata\": \"Pickl WF, Majdic O, Kohl P, et al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol. 1996; 157(9):3850-3859. (Clone-specific).\",\r\n          \"pubMedId\": \"8892615\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28408_748717\",\r\n          \"citationdata\": \"Zola H, Swart B, Banham A, et al. CD molecules 2006--human cell differentiation molecules.. J Immunol Methods. 2007; 319(1-2):1-5. (Clone-specific).\",\r\n          \"pubMedId\": \"17174972\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP29689_748717\",\r\n          \"citationdata\": \"Majdic O, Mai I, Pickl WF, Stockinger H, Knapp W. CDw92 (group 9) cluster workshop report. In: Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995:984-985. \",\r\n          \"pubMedId\": \"\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"dyeName\": \"BUV737\",\r\n          \"tdsCloneName\": \"VIM15\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"VIM15\",\r\n          \"workshopNumber\": \"V M15; HCDM 2006\",\r\n          \"immunogen\": \"Human Myeloid Cell Line MV4-11 \",\r\n          \"tdsCloneName\": \"VIM15\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748717_base\",\r\n          \"companionMaterialNumber\": \"612758\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"productType\": \"SingColorPureAntibody\",\r\n      \"baseMaterialNumber\": \"748683_base\",\r\n      \"pdpTemplate\": \"SFA\",\r\n      \"webName\": \"BUV737 Mouse Anti-Human CD62E 68-5H11\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Research Reagents,Single Color Antibodies (RUO) |Applications,Fluorochrome-conjugated antibodies,BD Horizon Brilliant™ Ultraviolet 737 (BUV737) (355 nm/737 nm) |Applications,OptiBuild,OptiBuild Reagents |BD Horizon Brilliant™ Reagents \",\r\n      \"keywords\": \"Brilliant Ultraviolet 737, BUV 737, Brilliant UV 737, Brilliant UV737; CD62 antigen-like family member E; CD62E; E-selectin; ELAM; ELAM-1; ELAM1; endothelial adhesion molecule 1; Endothelial leukocyte adhesion molecule 1; ESEL; LECAM2; leukocyte endothelial cell adhesion molecule 2; Leukocyte-endothelial cell adhesion molecule 2; LYAM2; SELE; selectin E\",\r\n      \"pageDescription\": \"The 68-5H11 monoclonal antibody specifically binds to CD62E.\",\r\n      \"tdsDocumentType\": \"ON_DEMAND_TDS\",\r\n      \"tdsDocumentLayout\": \"StandardSingleVial\",\r\n      \"labelDescription\": \"BUV737 Mouse Anti-Human CD62E\",\r\n      \"concentration\": \"0.2 mg/ml\",\r\n      \"storageBuffer\": \"Aqueous buffered solution containing ≤0.09% sodium azide.\",\r\n      \"tdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The 68-5H11 monoclonal antibody specifically binds to CD62E. This adhesion molecule is a 97-115 kDa type I transmembrane glycoprotein that is encoded by the </span><span style=\\\"font-style:italic;font-family:Times,serif;font-size:9pt;\\\">SELE </span><span style=\\\"font-family:Times,serif;font-size:9pt;\\\">gene. CD62E is also known as E-selectin, Endothelial-leukocyte adhesion molecule-1 (ELAM-1), and Leukocyte endothelial cell adhesion molecule 2 (LECAM-2). CD62E is minimally expressed by unstimulated endothelium. Activated endothelial cells upregulate surface CD62E expression in response to various activators including inflammatory cytokines such as Interleukin-1 and Tumor Necrosis Factor. CD62E plays a role in leucocyte extravasation by promoting leucocyte rolling on activated endothelial cells during inflammation. CD62E may also play a role in the metastasis of certain tumor cells. The adhesion between endothelial CD62E molecules and a carbohydrate ligand on neutrophils is inhibited by the mAb 68-5H11.</span>  </p>\",\r\n      \"alternativeName\": \"SELE; E-selectin; Selectin E; ELAM; ELAM1; ESEL; LECAM2\",\r\n      \"productNotices\": \"<ol><li>This antibody was developed for use in flow cytometry.</li><li>The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity.  However, verification testing has not been performed on all conjugate lots.</li><li>Researchers should determine the optimal concentration of this reagent for their individual applications.</li><li>An isotype control should be used at the same concentration as the antibody of interest.</li><li>Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.</li><li>For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.</li><li>Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.</li><li>BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.</li><li>BD Horizon Brilliant Ultraviolet 737 is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,227,187; 8,575,303; 8,354,239.</li></ol>\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"µg\",\r\n      \"preparationStorage\": \"Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV737 under optimal conditions that minimize unconjugated dye and antibody.\",\r\n      \"recomAssayProcedure\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment.  Fluorescent dye interactions may cause staining artifacts which may affect data interpretation.  The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions.  More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).</span>  </p>\",\r\n      \"otherTdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">The antibody was conjugated to BD Horizon™ BUV737 which is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This dye is a tandem fluorochrome of BD Horizon BUV395 with an Ex Max of 348-nm and an acceptor dye with an Em Max at 737-nm. BD Horizon Brilliant BUV737 can be excited by the ultraviolet laser (355 nm) and detected with a 740/35 filter.  Due to the excitation of the acceptor dye by other laser lines, there may be significant spillover into channels detecting Alexa Fluor® 700-like dyes (eg, 712/20-nm filter). </span>  </p>  <p></p>  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">Due to spectral differences between labeled cells and beads, using BD™ CompBeads can result in incorrect spillover values when used with BD Horizon BUV737 reagents. Therefore, the use of BD CompBeads or BD CompBeads Plus to determine spillover values for these reagents is not recommended. Different BUV737 reagents (eg, CD4 vs. CD45) can have slightly different fluorescence spillover therefore, it may also be necessary to use clone specific compensation controls when using these reagents.</span>  </p>\",\r\n      \"brand\": \"BD OptiBuild™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"3\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"Yes\",\r\n      \"reagentVialType\": \"500026863\",\r\n      \"fillVolume\": \"275 µl\",\r\n      \"nominalVolume\": \"0.25 ml\",\r\n      \"afSDate\": \"02/19/2019\",\r\n      \"rrid\": \"AB_2873087\",\r\n      \"specificity\": \"CD62E (E-Selectin)\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [\r\n        {\r\n          \"dyeName\": \"BUV737\",\r\n          \"formatStatement\": \"The BD Horizon Brilliant™ Ultraviolet 737 (BUV737) Dye is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This tandem fluorochrome is comprised of a BUV395 donor with an excitation maximum (Ex Max) of 350-nm and an acceptor dye with an emission maximum (Em Max) at 735-nm. BUV737, driven by BD innovation, is designed to be excited by the ultraviolet laser (355-nm) and detected using an optical filter centered near 740-nm (e.g., 740/35 bandpass filter). The acceptor dye can be excited by the Red (628–640nm) laser resulting in cross-laser excitation and fluorescence spillover. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.\",\r\n          \"emmisionmax\": \"735\",\r\n          \"excitationmax\": \"350\",\r\n          \"laserColor\": \"Ultraviolet\",\r\n          \"laserWavelength\": \"355\"\r\n        }\r\n      ],\r\n      \"productApplicationTest\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"applicationName\": \"FCM\",\r\n          \"applicationStatus\": \"QF\",\r\n          \"applicationDesc\": \"Flow cytometry\",\r\n          \"applicationStatusDesc\": \"Qualified\"\r\n        }\r\n      ],\r\n      \"medias\": [\r\n        \r\n      ],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"materialNumber\": \"748683\",\r\n          \"tdsRevision\": \"3\",\r\n          \"reagentVialType\": \"500026863\",\r\n          \"fillVolume\": \"275 µl\",\r\n          \"nominalVolume\": \"0.25 ml\",\r\n          \"afSDate\": \"02/19/2019\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"µg\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [\r\n        {\r\n          \"HPReferenceID\": \"HP12367_748683\",\r\n          \"citationdata\": \"Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28934_748683\",\r\n          \"citationdata\": \"Goda K, Tanaka T, Takeuchi E, Miyasaka M. CD62E Workshop Panel report. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:416-418. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP28935_748683\",\r\n          \"citationdata\": \"Vermont-Desroches C, Roy C, Marchand D, Wijdenes J. CD62E Workshop: The Workshop \\\"CD62E,\\\" CD62L,\\\" \\\"CD102\\\" and \\\"CD106\\\" monoclonal antibodies: Analysis of the monoclonal antibody specificity, epitope mapping, and biological activity. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:418-419. \",\r\n          \"pubMedId\": \"\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP10710_748683\",\r\n          \"citationdata\": \"Phillips ML, Nudelman E, Gaeta FC, et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science. 1990; 250(4984):1130-1132. (Biology).\",\r\n          \"pubMedId\": \"1701274\"\r\n        },\r\n        {\r\n          \"HPReferenceID\": \"HP12115_748683\",\r\n          \"citationdata\": \"Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 1989; 243(4895):1160-1165. (Biology).\",\r\n          \"pubMedId\": \"2466335\"\r\n        }\r\n      ],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"reactivityStatus\": \"TD\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"Tested in Development\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"dyeName\": \"BUV737\",\r\n          \"tdsCloneName\": \"68-5H11\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        \r\n      ],\r\n      \"clone\": [\r\n        {\r\n          \"polyclonal\": \"FALSE\",\r\n          \"hostStrain\": \"\",\r\n          \"entrezGeneId\": \"\",\r\n          \"isoType\": \"IgG1, κ\",\r\n          \"tdsCloneDisplayName\": \"68-5H11\",\r\n          \"workshopNumber\": \"VI A090\",\r\n          \"immunogen\": \"\",\r\n          \"tdsCloneName\": \"68-5H11\",\r\n          \"hostSpecies\": \"Mouse\",\r\n          \"molecularWeight\": \"\"\r\n        }\r\n      ],\r\n      \"companionProduct\": [\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"564219\",\r\n          \"companionOrdinal\": \"1\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"554656\",\r\n          \"companionOrdinal\": \"2\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"554657\",\r\n          \"companionOrdinal\": \"3\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"563794\",\r\n          \"companionOrdinal\": \"4\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"555899\",\r\n          \"companionOrdinal\": \"5\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"349202\",\r\n          \"companionOrdinal\": \"6\",\r\n          \"companionType\": \"Recommended\"\r\n        },\r\n        {\r\n          \"baseMaterialNumber\": \"748683_base\",\r\n          \"companionMaterialNumber\": \"612758\",\r\n          \"companionOrdinal\": \"7\",\r\n          \"companionType\": \"Recommended\"\r\n        }\r\n      ]\r\n    }\r\n  ]\r\n}"
				},
				"url": {
					"raw": "http://localhost:4502/bin/catalogUpdatePathServlet.hp.json",
					"protocol": "http",
					"host": [
						"localhost"
					],
					"port": "4502",
					"path": [
						"bin",
						"catalogUpdatePathServlet.hp.json"
					]
				}
			},
			"response": []
		},
		{
			"name": "local Copy",
			"request": {
				"auth": {
					"type": "basic",
					"basic": [
						{
							"key": "password",
							"value": "admin",
							"type": "string"
						},
						{
							"key": "username",
							"value": "admin",
							"type": "string"
						}
					]
				},
				"method": "POST",
				"header": [],
				"body": {
					"mode": "raw",
					"raw": "{\r\n  \"products\": [\r\n    {\r\n      \"productType\": \"KitProduct\",\r\n      \"baseMaterialNumber\": \"CYT-CS-R-50_base\",\r\n      \"pdpTemplate\": \"Kit\",\r\n      \"webName\": \"Cycloscope Reagent\",\r\n      \"superCategory\": \"Products,Reagents,Flow Cytometry Reagents,Clinical Discovery Research,Controls and Supporting Reagents (RUO, GMP) \",\r\n      \"tdsDocumentType\": \"PUBLISHED_TDS\",\r\n      \"labelDescription\": \"Cycloscope Reagent\",\r\n      \"tdsDescription\": \"\",\r\n      \"sizeQty\": \"50\",\r\n      \"sizeUOM\": \"Tests\",\r\n      \"preparationStorage\": \"\",\r\n      \"otherTdsDescription\": \"  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">Cycloscope™ is an exclusive product line for cell DNA content studies by flow cytometry.</span>  </p>  <p></p>  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">DNA quantification and cell cycle phases study provide relevant information for prognostic, evaluation and follow-up of patients with solid tumors or hematological malignancies. It has been proved that DNA ploidy is characteristic of malignant neoplasm for some type of diseases and can be associated with better or worse prognosis.</span>  </p>  <p></p>  <p>    <span style=\\\"font-family:Times,serif;font-size:9pt;\\\">Cycloscope™ main advantage is its capability to estimate cell DNA contents on tumor cells based on their specific immunophenotype in a single tube.</span>  </p>\",\r\n      \"brand\": \"BD Cytognos™\",\r\n      \"productApprovalStatus\": \"approved\",\r\n      \"dataSource\": \"HP\",\r\n      \"regulatoryStatus\": \"RUO\",\r\n      \"tdsRevision\": \"1\",\r\n      \"isDriedReagent\": \"No\",\r\n      \"isSirigenDye\": \"No\",\r\n      \"afSDate\": \"06/06/2023\",\r\n      \"componentMaterialNumber\": \"CYT-CSR50DNA,CYT-CSR50L\",\r\n      \"specificity\": \"CYCLOSCOPE REAGENT\",\r\n      \"isVariantOnly\": \"\",\r\n      \"bdFormat\": [],\r\n      \"productApplicationTest\": [],\r\n      \"medias\": [],\r\n      \"variants\": [\r\n        {\r\n          \"baseMaterialNumber\": \"CYT-CS-R-50_base\",\r\n          \"materialNumber\": \"CYT-CS-R-50\",\r\n          \"tdsRevision\": \"1\",\r\n          \"reagentVialType\": \"\",\r\n          \"fillVolume\": \"\",\r\n          \"nominalVolume\": \"\",\r\n          \"afSDate\": \"06/06/2023\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"Tests\"\r\n        }\r\n      ],\r\n      \"referenceDetails\": [],\r\n      \"speciesReactivity\": [\r\n        {\r\n          \"baseMaterialNumber\": \"CYT-CS-R-50_base\",\r\n          \"reactivityStatus\": \"\",\r\n          \"species\": \"Hu\",\r\n          \"reactivityStatusDesc\": \"\",\r\n          \"speciesDescription\": \"Human\"\r\n        }\r\n      ],\r\n      \"conjugate\": [\r\n        {\r\n          \"baseMaterialNumber\": \"CYT-CS-R-50_base\",\r\n          \"dyeName\": \"\",\r\n          \"tdsCloneName\": \"\"\r\n        }\r\n      ],\r\n      \"manufacturingComponent\": [\r\n        {\r\n          \"componentMaterialNumber\": \"CYT-CSR50DNA\",\r\n          \"description\": \"DNA Labelling Solution\",\r\n          \"alternativeName\": \"\",\r\n          \"storageBuffer\": \"\",\r\n          \"volPerTest\": \"\",\r\n          \"concentration\": \"\",\r\n          \"tdsCloneName\": \"\",\r\n          \"immunogen\": \"\",\r\n          \"isoType\": \"\",\r\n          \"targetMW\": \"\",\r\n          \"workshopNumber\": \"\",\r\n          \"componentDescription\": \"\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"Tests (1 ea)\",\r\n          \"entrezGeneID\": \"\",\r\n          \"barcodeSequence\": \"\",\r\n          \"seqId\": \"\",\r\n          \"beadPosition\": \"\",\r\n          \"reactivityStatus\": \"\",\r\n          \"species\": \"\",\r\n          \"reactivityStatusDesc\": \"\",\r\n          \"speciesCode\": \"\",\r\n          \"specificity\": \"\",\r\n          \"dyeName\": \"Buffer\"\r\n        },\r\n        {\r\n          \"componentMaterialNumber\": \"CYT-CSR50L\",\r\n          \"description\": \"Quicklysis™\",\r\n          \"alternativeName\": \"\",\r\n          \"storageBuffer\": \"\",\r\n          \"volPerTest\": \"\",\r\n          \"concentration\": \"\",\r\n          \"tdsCloneName\": \"\",\r\n          \"immunogen\": \"\",\r\n          \"isoType\": \"\",\r\n          \"targetMW\": \"\",\r\n          \"workshopNumber\": \"\",\r\n          \"componentDescription\": \"\",\r\n          \"sizeQty\": \"50\",\r\n          \"sizeUOM\": \"Tests (1 ea)\",\r\n          \"entrezGeneID\": \"\",\r\n          \"barcodeSequence\": \"\",\r\n          \"seqId\": \"\",\r\n          \"beadPosition\": \"\",\r\n          \"reactivityStatus\": \"\",\r\n          \"species\": \"\",\r\n          \"reactivityStatusDesc\": \"\",\r\n          \"speciesCode\": \"\",\r\n          \"specificity\": \"\",\r\n          \"dyeName\": \"Buffer\"\r\n        }\r\n      ],\r\n      \"clone\": [],\r\n      \"companionProduct\": []\r\n    }\r\n  ]\r\n}",
					"options": {
						"raw": {
							"language": "json"
						}
					}
				},
				"url": {
					"raw": "http://localhost:4502/bin/catalogUpdatePathServlet.hp.json",
					"protocol": "http",
					"host": [
						"localhost"
					],
					"port": "4502",
					"path": [
						"bin",
						"catalogUpdatePathServlet.hp.json"
					]
				}
			},
			"response": []
		}
	]
}